Table 5.
Cytokines of experimental and control groups
| Variable | Control | LP | UP |
|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | |
| 95 % confidence interval for mean | 95 % confidence interval for mean | 95 % confidence interval for mean | |
| Before training | |||
| Irisin, ng/mL | 169.62 ± 36.55 (143.47–195.77) | 230.00 ± 55.88 (203.19–257.06) † | 202.10 ± 52.30 (176.89–227.31) |
| TLR-4, ng/mL | 9.54 ± 5.45 (5.74–13.54) | 7.80 ± 4.61 (5.34–10.26) | 6.69 ± 4.40 (4.57–8.81) |
| BDNF‡, pg/mL | 1433.18 ± 361.42 | 1530.13 ± 159.24 | 1540.57 ± 107.46 |
| IL-1β‡, pg/mL | 31.06 ± 38.79 | 6.83 ± 16.27 | 15.73 ± 27.85 |
| IL-1ra‡, pg/mL | 110.85 ± 272.20 | 149.32 ± 276.56 | 1411.18 ± 1365.79 |
| IL-10‡, pg/mL | 74.94 ± 49.48 | 1664.89 ± 1439.63 | 2538.22 ± 1937.41 |
| IL-15‡, pg/mL | 12.03 ± 11.12 | 230.16 ± 369.67 | 280.74 ± 280.23 |
| After training | |||
| Irisin, ng/mL | 173.64 ± 36.35 (145.70–201.59) | 217.49 ± 53.55 (191.68–243.31) | 202.23 ± 76.94 (165.14–239.32) |
| TLR4, ng/mL | 9.46 ± 5.75 (5.04–13.88) | 7.21 ± 5.50 (4.33–10.09) | 6.24 ± 4.59 (4.02–8.45) |
| BDNF‡, pg/mL | 1473.20 ± 359.08 | 1528.72 ± 148.73 | 1689.28 ± 234.54 |
| IL-1 β‡, pg/mL | 43.78 ± 45.14 | 6.55 ± 15.58 | 15.21 ± 27.65 |
| IL-1ra‡, pg/mL | 123.65 ± 288.08 | 156.44 ± 202.87 | 1015.80 ± 1311.87 |
| IL-10‡, pg/mL | 102.17 ± 21.21 | 1139.33 ± 1342.02 | 2112.67 ± 1600.71 |
| IL-15‡, pg/mL | 14.30 ± 12.43 | 175.46 ± 267.04 | 267.23 ± 265.91 |
Data are expressed by means and SD
LP linear periodization training, UP undulating periodization training, TLR-4 tool-like receptor-4, BDNF brain-derived neurotrophic factor, IL-1β interleukin-1 beta, IL-1ra interleukin-1 receptor antagonist, IL-10 interleukin-10, IL-15 interleukin-15
†Difference between LP vs. control at the same time point (<0.05)
‡These variables are not normally distributed